Biovitrum enters agreement with Karolinska Development
Leukemia project to be pursued in a jointly owned project company
19-Mar-2009 -
Biovitrum AB and Karolinska Development signed an agreement to establish a jointly owned project company. This company will receive all rights to further develop, market and sell Biovitrum's pharmaceutical project FLT3 against leukemia.
Karolinska Development will finance the project with a ...
acute myeloid leukemia
biopharmaceuticals
Biovitrum
+1